Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03016637 | Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy(PANCOBE) | completed | Phase 1 / Phase 2 | 40 | Odense University HospitalOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT00901680 | Creation of the BioBank, Early Detection and Discovery Biomarkers | completed | — | 3,028 | Corewell Health EastOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02720666 | K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability | completed | Phase 1 | 12 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT03009253 | Translational Research on Locally Advanced Pancreatic Adenocarcinoma(TRLAPA) | unknown | N/A | 40 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 4, 2017 | clinicaltrials |
| NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | completed | Phase 3 | 100 | Mayo ClinicOTHER | 1 | Dec 22, 2016 | clinicaltrials |
| NCT02124317 | Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer(NAPSPAC) | unknown | Phase 2 | 60 | Chinese PLA General HospitalOTHER | 1 | Dec 22, 2016 | clinicaltrials |
| NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | completed | Phase 1 | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 20, 2016 | clinicaltrials |
| NCT00448838 | Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | N/A | 42 | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT00112528 | Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 53 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00966277 | Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | completed | Phase 4 | 87 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 12, 2016 | clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT00059826 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | completed | Phase 2 | 89 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT02984501 | Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer | completed | Phase 2 | 41 | Campus Bio-Medico UniversityOTHER | 0 | Dec 7, 2016 | clinicaltrials |
| NCT02839954 | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 10 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 6, 2016 | clinicaltrials |
| NCT02587689 | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor | unknown | Phase 1 / Phase 2 | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 5, 2016 | clinicaltrials |
| NCT02981641 | IORT Versus CCRT for Pancreatic Cancer(IVCPC) | unknown | N/A | 100 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT01947166 | Pancreatic Resection, Malnutrition and Readmission | completed | N/A | 38 | Duke UniversityOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT01642875 | Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy | unknown | Phase 4 | 96 | Medical University of WarsawOTHER | 1 | Nov 23, 2016 | clinicaltrials |
| NCT02854072 | A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients | unknown | Phase 3 | 148 | Samsung Pharmaceutical Co., Ltd.INDUSTRY | 1 | Nov 22, 2016 | clinicaltrials |
| NCT01369420 | NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 2 | 10 | Angiodynamics, Inc.INDUSTRY | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02954302 | Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy | unknown | N/A | 140 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT02565641 | A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 63 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01111591 | Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer | unknown | Phase 4 | 220 | Seoul National University HospitalOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02607826 | Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors | unknown | N/A | 298 | University Hospital TuebingenOTHER | 0 | Oct 28, 2016 | clinicaltrials |
| NCT02945267 | Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer | unknown | Phase 4 | 60 | Chinese PLA General HospitalOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT01041612 | Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi | completed | Phase 4 | 120 | Taewoong Medical Co., Ltd.INDUSTRY | 2 | Oct 21, 2016 | clinicaltrials |
| NCT00499486 | Sirolimus in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 47 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT01661114 | A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers | completed | Phase 2 | 39 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00841607 | Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy | completed | N/A | 162 | Tom Baker Cancer CentreOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT00260364 | Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer(TARGET) | completed | Phase 1 / Phase 2 | 44 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01050426 | A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)(PERU) | terminated | Phase 2 | 17 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT02929797 | Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer(AKT) | unknown | Early Phase 1 | 72 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 11, 2016 | clinicaltrials |
| NCT02851381 | Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 7, 2016 | clinicaltrials |
| NCT01521325 | A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers | completed | Phase 1 | 6 | MorphotekINDUSTRY | 1 | Sep 30, 2016 | clinicaltrials |
| NCT00726037 | A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer | terminated | Phase 2 | 7 | Loyola UniversityOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02329717 | Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma | unknown | Phase 2 | 50 | Phoenix Biotechnology, IncINDUSTRY | 1 | Sep 29, 2016 | clinicaltrials |
| NCT01188109 | Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision | terminated | Phase 2 | 25 | Emory UniversityOTHER | 1 | Sep 28, 2016 | clinicaltrials |
| NCT00310115 | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | completed | — | 469 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT02909296 | Endoscopic Drainage of Collections After Pancreatic Surgery(COLLECTOR) | completed | — | 40 | Institut Paoli-CalmettesOTHER | 0 | Sep 21, 2016 | clinicaltrials |
| NCT00336700 | A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer | terminated | Phase 2 | 25 | Herbert J. Zeh, III MD, FACSOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT01104116 | Use of PET Imaging to Distinguish Malignant From Benign IPMN | terminated | N/A | 1 | Columbia UniversityOTHER | 1 | Sep 15, 2016 | clinicaltrials |
| NCT02900677 | Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery | unknown | N/A | 168 | National Taiwan University HospitalOTHER | 1 | Sep 14, 2016 | clinicaltrials |
| NCT01094561 | Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients | completed | N/A | 23 | Elizabeth HechtOTHER | 1 | Sep 9, 2016 | clinicaltrials |
| NCT02150135 | Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients | completed | Phase 1 | 10 | Seoul National University HospitalOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01935453 | A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer | completed | Phase 1 | 18 | OrienGene Biotechnology Ltd.INDUSTRY | 1 | Sep 1, 2016 | clinicaltrials |
| NCT00681798 | Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma | completed | Phase 1 | 8 | SanofiINDUSTRY | 1 | Aug 29, 2016 | clinicaltrials |
| NCT00642733 | A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer | terminated | Phase 4 | 6 | Hoffmann-La RocheINDUSTRY | 1 | Aug 24, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Jan 11, 2017source: clinicaltrials